8-K

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): March 3, 2009

Rochester Medical Corporation
__________________________________________
(Exact name of registrant as specified in its charter)

Minnesota	0-18933	41-1613227
_____________________ (State or other jurisdiction	_____________ (Commission	______________ (I.R.S. Employer
of incorporation)	File Number)	Identification No.)
One Rochester Medical Drive, Stewartville, Minnesota		55976
_________________________________ (Address of principal executive offices)		___________ (Zip Code)

Registrant’s telephone number, including area code: 507-533-9600

Not Applicable
______________________________________________
Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01 Other Events.

On March 3, 2009, Rochester Medical Corporation (the "Company") issued a press release announcing the Company’s intention to renew activity under its share repurchase program. A copy of the press release that discusses these matters is filed as Exhibit 99.1 to, and incorporated by reference in, this report.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

99.1 Press release dated March 3, 2009

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Rochester Medical Corporation
March 3, 2009	By:	/s/ Davis A. Jonas
		Name: Davis A. Jonas
		Title: Chief Financial Officer

Exhibit Index

Exhibit No.	Description
99.1	Press Release dated March 3, 2009

EX-99.1

Exhibit 99.1

For Immediate Release

March 3, 2009

Rochester Medical Renews Share Repurchase Activity

Stewartville, MN March 3, 2009

Rochester Medical Corporation (NASDAQ: ROCM) today announced its intention to repurchase some of the company’s outstanding common shares pursuant to its previously authorized share repurchase program. The company plans to repurchase shares from time to time on the open market, or pursuant to negotiated or block transactions in accordance with applicable SEC guidelines and regulations. Additionally, the company may make repurchases pursuant to trading plans meeting the requirements of Rule 10b5-1 of the Securities Exchange Act of 1934.

The Company’s board of directors approved a repurchase program back in fiscal 2000, authorizing the company to repurchase up to 2,000,000 shares. The only repurchase activity on this plan was in 2000 and 2001 when the company repurchased 42,000 shares. The timing of the repurchases and the number of shares puchased under this plan will continue to depend on business and financial market conditions.

“We believe the current valuation of Rochester Medical’s common stock makes the repurchase of our equity an attractive investment for the company and will enhance shareholder value,” said Anthony J. Conway, Chairman and CEO of Rochester Medical. “Having $37 million in available cash and a growing business that is generating cash flow allows us to invest in Rochester Medical stock, as well as other strategic initiatives,” Conway added.

Rochester Medical Corporation develops, manufactures, and markets disposable medical catheters and devices for urological and continence care applications. The Company markets under its own Rochester Medical^® brand and under existing private label arrangements.

For further information, please contact Anthony J. Conway, President and Chief Executive Officer of Rochester Medical Corporation at (507) 533-9600. More information about Rochester Medical is available on its website at http://www.rocm.com.